Analytical Data
-
Gene name
CCDC33
- Application
-
Alternative Names
CCDC33Coiled-coil domain-containing Protein 33; Cancer/testis antigen 61; CT61
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N5R6
-
Expression Region
1-341aa
-
AA Sequence
MGEPGPPSPPAPKAAPGLIDSFSEMNNYRRAMQKMAEDILSLRRQASILEGENRILRSRLAQQEEEEGQGKASEAQNTVSMKQKLLLSELDMKKLRDRVQHLQNELIRKNDREKELLLLYQAQQPQAALLKQYQGKLQKMKALEETVRHQEKVIEKMERVLEDRLQDRSKPPPLNRQQGKPYTGFPMLSASGLPLGSMGENLPVELYSVLLAENAKLRTELDKNRHQQAHHSAATGPAGGPRGVGSRRRLDREATRDAWPRPLRVHRDPARTGSPLWYFRQVQPPGQAGTRSEPDPVPGKPVRGLSSTLGTREAGSGHTAAGARKRFQAPLELHHHRTACE
-
Molecular Weight
64.7 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC33, known as Coiled-Coil Domain Containing 33, is a protein that has garnered attention in the field of molecular biology due to its potential involvement in various cellular processes, including cell signaling, cytoskeletal organization, and cellular response to stress. Emerging research suggests that CCDC33 may play a crucial role in certain diseases, particularly in cancer, where its expression levels can significantly impact tumor progression and metastasis. The protein’s coiled-coil structure suggests it may interact with other proteins, highlighting its potential function in molecular complexes that regulate essential cellular functions. Understanding the molecular mechanisms underlying CCDC33’s activity is critical for elucidating its biological roles and therapeutic implications. Recent studies have increasingly focused on the recombination and functional analysis of CCDC33 to explore its interactions and pathways, aiming to identify its role in cellular homeostasis and disease states. This research is pivotal for developing targeted therapies that can modulate CCDC33’s function in pathological conditions, making it a significant focus in translational research efforts.
